SCHEMBL5519765

SCHEMBL5519765

Cc1ccnc(-c2cc(C(=O)NC(C)(C)C)nn2-c2cccnc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.53
CNR2 P34972 5/20 0.53
CYP2A6 P11509 1/20 0.44
MARS1 P56192 3/20 0.41
ANO1 Q5XXA6 3/20 0.39
RIPK1 Q13546 1/20 0.39
RPA1 P27694 1/20 0.38
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SLC16A3 O15427 1/20 0.36
SLC16A1 P53985 1/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
ALOX12 P18054 1/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5522031 0.89 CNR1 (0.52) CNR1CNR2CYP2A6MARS1ANO1
SCHEMBL5528493 0.87 CNR1 (0.52) CNR1CNR2MARS1ANO1RIPK1
SCHEMBL5521076 0.85 MARS1 (0.53) CYP2A6MARS1RPA1ALDH1A1MEN1
SCHEMBL5522084 0.84 CNR1 (0.52) CNR1CNR2MARS1ANO1RIPK1
SCHEMBL5526588 0.84 CNR1 (0.52) CNR1CNR2MARS1RIPK1MEN1
SCHEMBL5526269 0.84 CNR1 (0.51) CNR1CNR2MARS1
SCHEMBL5529097 0.84 CNR1 (0.51) CNR1CNR2MARS1RIPK1MEN1
SCHEMBL5522135 0.84 CNR1 (0.51) CNR1CNR2MARS1RIPK1MEN1
SCHEMBL5529104 0.84 CNR1 (0.51) CNR1CNR2MARS1MEN1KMT2A
SCHEMBL5524391 0.83 CNR1 (0.38) CNR1CNR2ANO1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 CNR1 76/4885CNR2 43/4885CYP2A6 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.